Journal of Neuroimmunology
Volume 217, Issue 1 , Pages 8-9 , 10 December 2009

Multiple pathways in prevention of immune-mediated brain disorders: Implications for the prevention of autism

Received 14 September 2009 ,Accepted 14 September 2009.

References 

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA Press; 1994;
  2. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 1995;25:63–77
  3. Blatt GJ. GABAergic cerebellar system in autism: a neuropathological and developmental perspective. Int. Rev. Neurobiol. 2005;71:167–178
  4. Boris M, Kaiser CC, Goldblatt A, Elice MW, Edelson SM, Adams JB, et al. Effect of pioglitazone treatment on behavioral symptoms in autistic children. J. Neuroinflammation. 2007;4:3
  5. Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 2006;32:200–202
  6. Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Minicolumnar pathology in autism. Neurology. 2002;58:428–432
  7. Cattaneo E, Conti L, De-Fraja C. Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci. 1999;22(8):365–369
  8. Chiba T, Yamada M, Sasabe J, Terashita K, Shimoda M, Matsuoka M, et al. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol. Psychiatry. 2009;14:206–222
  9. Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA. 2003;290:337–344
  10. Fatemi SH, Halt AR. Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse. 2001;42:281–284
  11. Fatemi SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, Akhter P, et al. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol. Psychiatry. 1999;4:145–154
  12. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR. Glutamic acid decarboxylase 65 and 67kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry. 2002;52:805–810
  13. Fatemi SH, Pearce DA, Brooks AI, Sidwell RW. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse. 2005;57:91–99
  14. Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, Lee S, et al. Reelin signaling is impaired in autism. Biol. Psychiatry. 2005;57:777–787
  15. Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, et al. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res. 2008;99:56–70
  16. Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD. Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum. 2009;8:64–69
  17. Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD. GABA(A) receptor downregulation in brains of subjects with autism. J. Autism Dev. Disord. 2009;39:223–230
  18. Kaplan JM, Herzyk DJ, Ruggieri EV, Bartus JO, Esser KM, Bugelski PJ. Effect of TNF alpha production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:C. Toxicology. 1995;95:187–196
  19. Kido H, Okumura Y, Yamada H, Le TQ, Yano M. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Curr. Pharm. Des. 2007;13:405–414
  20. Laurence JA, Fatemi SH. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum. 2005;4:206–210
  21. Liu AL, Liu B, Qin HL, Lee SM, Wang YT, Du GH. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 2008;74:847–851
  22. Meyer U, Feldon J, Fatemi SH. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci. Biobehav. Rev. 2009;33:1061–1079
  23. Miyamoto D, Hasegawa S, Sriwilaijaroen N, Yingsakmongkon S, Hiramatsu H, Takahashi T, et al. Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells. Biol. Pharm. Bull. 2008;31:217–222
  24. Nagai T, Moriguchi R, Suzuki Y, Tomimori T, Yamada H. Mode of action of the anti-influenza virus activity of plant flavonoid, 5, 7, 4'-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis. Antivir. Res. 1995;26:11–25
  25. Oblak A, Gibbs TT, Blatt GJ. Decreased GABA(A) receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Res. 2009;2:205–219
  26. Palmen SJ, van Engeland H, Hof PR, Schmitz C. Neuropathological findings autism. Brain. 2004;127:2572–2583
  27. Pang Y, Fan LW, Zheng B, Cai Z, Rhodes PG. Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats. Neuroscience. 2006;141:745–755
  28. Parker-Athill E, Lou D, Bailey A, Giunta B, Tian J, Shytle D, et al. Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism. J. Neuroimmunol. 2009;217:20–27
  29. Patterson PH. Maternal effects on schizophrenia risk. Science. 2007;318:576–577
  30. Patterson PH. Immune involvement in schizophrenia and autism: etiology, pathology, and animal models. Behav. Brain Res. 2009;204:313–321
  31. Penner JD, Brown AS. Prenatal infectious and nutritional factors and risk of adult schizophrenia. Expert Rev. Neurother. 2007;7:797–805
  32. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, et al. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry. 2001;158:1058–1066
  33. Realmuto GM, Azeem MW. Autistic disorder. In:  Fatemi SH,  Clayton P editor. The Medical Basis of Psychiatry. New York: Humana Press; 2008;p. 355–374
  34. Saltzman A, Stone M, Franks C, Searfoss G, Munro R, Jaye M, et al. Cloning and characterization of human Jak-2 kinase: high mRNA expression in immune cells and muscle tissue. Biochem. Biophys. Res. Commun. 1998;246:627–633
  35. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 2007;282:20059–20063
  36. Shi L, Fatemi SH, Sidwell RW, Patterson PH. A mouse model of mental illness: maternal influenza infection causes behavioral and pharmacological abnormalities in the offspring. J. Neurosci. 2003;23:297–302
  37. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007;27:10695–10702
  38. Sriram K, Benkovic SA, Hebert MA, Miller DB, O'Callaghan JP. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?. J. Biol. Chem. 2004;279:19936–19947
  39. Stephanou A, Latchman DS. Opposing actions of STAT-1 and STAT-3. Growth Factors. 2005;23:177–182
  40. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005;57:67–81
  41. Wang X, Jia W, Zhao A, Wang X. Anti-influenza agents from plants and traditional Chinese medicine. Phytother. Res. 2006;20:335–341
  42. Zhang H, Su YA, Hu P, Yang J, Zheng B, Wu P, et al. Signature patterns revealed by microarray analyses of mice infected with influenza virus A and Streptococcus pneumoniae. Microbes Infect. 2006;8:2172–2185

PII: S0165-5728(09)00357-9

doi: 10.1016/j.jneuroim.2009.09.011

Journal of Neuroimmunology
Volume 217, Issue 1 , Pages 8-9 , 10 December 2009

Article Tools